Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity

v3.10.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Preferred stock, shares outstanding, beginning of period at Dec. 31, 2015   14,666,667        
Series A Redeemable Convertible Preferred Stock, beginning of period at Dec. 31, 2015   $ 28,602        
Shares, Outstanding, Beginning Balance at Dec. 31, 2015     75,820,307      
Outstanding balance, beginning of period at Dec. 31, 2015 $ 208,522   $ 76 $ 231,497 $ 0 $ (23,051)
Common stock issuance ESPP plan (in shares) 98,672   98,672      
Common stock issuance ESPP plan $ 736     736    
Redemption of Series A Preferred stock (in shares)   8,066,667        
Redemption of Series A Preferred Stock   $ (55,000)        
Issuance of common stock for stock options (in shares) 2,483,519   2,443,472      
Issuance of common stock for stock options $ 3,299   $ 3 3,296    
Stock issuance fees and expenses (267)     (267)    
Issuance of restricted stock (in shares)     43,332      
Issuance of stock for warrant exercises     165,375      
Beneficial conversion feature reversal (24,596) (24,596)   (24,596)    
Change in beneficial conversion feature (6,663) (6,663)       (6,663)
Deemed dividends on preferred stock 18,011 $ 18,011       18,011
Stock compensation expense - warrants 460     460    
Stock comp. exp. - options and restricted stock 4,978     4,978    
Net income (loss) (6,142)          
Preferred stock, shares outstanding, end of period at Dec. 31, 2016   6,600,000        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2016   $ 22,873        
Shares, Outstanding, Ending Balance at Dec. 31, 2016     78,571,158      
Outstanding balance, end of period at Dec. 31, 2016 $ 162,316   $ 79 216,104 0 (53,867)
Common stock issuance ESPP plan (in shares) 108,599   108,599      
Common stock issuance ESPP plan $ 844     844    
Issuance of Series A Preferred Stock (in shares)   264,000        
Issuance of common stock for stock options (in shares) 565,569   595,506      
Issuance of common stock for stock options $ 1,960     1,960    
Stock issuance fees and expenses (218)     (218)    
Foreign currency translation adjustments 44       44  
Gain (loss) on effective cash flow hedge 230       230  
Issuance of restricted stock (in shares)     822,711      
Issuance of restricted stock 4,095   $ 1 4,094    
Issuance of stock for warrant exercises     364,600      
Deemed dividends on preferred stock 3,645 $ 3,645       3,645
Amortization of beneficial conversion feature 6,097 $ (6,097)   (805)   6,902
ESPP Expense 96     96    
Stock comp. exp. - options and restricted stock 6,345     6,345    
Net income (loss) $ (396)         (396)
Preferred stock, shares outstanding, end of period at Dec. 31, 2017 6,864,000 6,864,000        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2017   $ 32,615        
Shares, Outstanding, Ending Balance at Dec. 31, 2017     80,462,574      
Outstanding balance, end of period at Dec. 31, 2017 $ 171,962   $ 80 230,030 274 (58,422)
Common stock issuance ESPP plan (in shares) 113,503   117,146      
Common stock issuance ESPP plan $ 1,050     1,050    
Redemption of Series A Preferred stock (in shares)   6,864,000        
Redemption of Series A Preferred Stock   $ (50,096)        
Issuance of common stock for stock options (in shares) 1,570,211   1,553,544      
Issuance of common stock for stock options $ 8,598   $ 2 8,596    
Issuance of common stock - Public Offering (in shares)     11,270,000      
Issuance of common stock - Public Offering 135,071   $ 11 135,060    
Stock issuance fees and expenses (354)     (354)    
Foreign currency translation adjustments (122)       (68) (54)
Gain (loss) on effective cash flow hedge (785)       (785)  
Issuance of restricted stock (in shares)     62,182      
Issuance of restricted stock (297)     (297)    
Issuance of common stock - Acquisition (in shares)     999,994      
Issuance of common stock - Acquisition 13,243   $ 1 13,242    
Deemed dividends on preferred stock 10,198 10,198       10,198
Amortization of beneficial conversion feature 16,358 1,792   20,929   (4,571)
Gain on redemption of preferred stock 9,075 $ 9,075       9,075
ESPP Expense 243     243    
Stock comp. exp. - options and restricted stock 6,640     6,640    
Net income (loss) $ 2,640         2,640
Preferred stock, shares outstanding, end of period at Dec. 31, 2018 0 0        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2018   $ 0        
Shares, Outstanding, Ending Balance at Dec. 31, 2018     94,465,440      
Outstanding balance, end of period at Dec. 31, 2018 $ 320,443   $ 94 $ 372,186 $ (579) $ (51,258)